Combined Associations of Diabetes and Depressive Symptoms on Cognitive Impairment Risk in the Population Aged 60 or Older: Cross-Cohort Comparisons From NHANES and CHARLS
Integrating metabolic and mental health screening and interventions may optimize cognitive outcomes in high-risk older adult populations, with a significant additive interaction between diabetes and depressive symptoms found only in the CHARLS cohort.
Abstract
Objective Diabetes mellitus (DM) and cognitive impairment (CoI) are correlated, but the combined impact of depressive symptoms on CoI risk in older adults remains unclear. Methods This study included 1,200 U.S. adults aged ≥60 years (National Health and Nutrition Examination Survey, NHANES) and 1,500 Chinese adults (China Health and Retirement Longitudinal Study, CHARLS). DM was defined by laboratory measures or self-report; depressive symptoms were assessed via the Patient Health Questionnaire-9 (PHQ-9) (NHANES) and CES-D-10 (CHARLS); CoI was measured using the CERAD battery (NHANES) and situational memory/mental integrity scores (CHARLS). Multivariate logistic regression estimated associations of DM and depressive symptoms with CoI. Additive interaction was evaluated by the relative excess risk due to interaction (RERI), attributable proportion (AP), and synergy index (S). Restricted cubic spline (RCS) analyses examined nonlinear DM–depressive symptoms interactions. Results Both DM and depressive symptoms were independently and significantly associated with CoI. After multivariate adjustment, diabetic patients exhibited significantly increased CoI risk; depressive symptoms similarly elevated CoI risk. Interaction analysis revealed an additive effect when DM co-occurred with depressive symptoms in CHARLS but not in NHANES. Mediation analyses further suggest bidirectional associations: in CHARLS, diabetes and depressive symptoms appear to mediate each other’s effects on CoI. Additionally, RCS analysis in NHANES indicated a nonlinear interaction between depressive symptom severity (PHQ-9) and DM on CoI (p<0.05). Conclusion The observed associations varied across cohorts, with a significant additive interaction between diabetes and depressive symptoms found only in the CHARLS cohort. Integrating metabolic and mental health screening and interventions may optimize cognitive outcomes in high-risk older adult populations.
Diabetes was strongly associated with lower MMSE performance and a higher prevalence of MMSE-defined impairment in this hospital-based sample, and the findings require confirmation in larger prospective studies.
Rachid Aithammou, M. Ben-el-caid· Diabetology· 0 citations
Depression is associated with greater risks for incident cardiovascular disease and all-cause death in people with type 2 diabetes and minor contributions from metabolic risk factors on these associations, highlighting the need for enhanced screening for depression and integrated care.
E. W. Chow, E. Lau, Hong-Jiang Wu et al.· Journal of Affective Disorde...· 0 citations
In this nationally representative sample of U.S. adults, the CHG index was positively associated with the prevalence of depressive symptoms and it was suggested that HOMA-IR and ALB may statistically account for part of this association.
Yan Chen, Ning-Kun Xiao, Qing-Zhi Zhou et al.· Psychiatry Research· 0 citations
Cumulative TyG was modestly associated with higher cognitive performance and lower odds of MCI in cross-sectional analyses, but not with follow-up cognitive performance.
Li-Xin Ma, Yan-Jun Ma, Chao-Fan Geng et al.· Journal of Alzheimer's Disea...· 0 citations
Identifying distinct frailty profiles allows nurses to develop targeted rehabilitation programs and Tailored nursing interventions targeting modifiable associated factors are essential for this population of older adults with post-stroke cognitive impairment.
Wei Zhao, Chang-Zai Li, Pei-Qi Li et al.· Rehabilitation Nursing· 0 citations
Marked BW change was associated with subsequent dementia risk in young and middle-aged adults with T2DM and depression, and BW trajectories may serve as clinically observable risk markers, although associations involving extreme BW change should be interpreted cautiously.
Hae Yeon Kang, Kyungdo Han, D. Yoon et al.· Diabetes, obesity and metabo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.